Specify a stock or a cryptocurrency in the search bar to get a summary
ONWARD MEDICAL BV EO -12
63EOnward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands. Address: Schimmelt 2, Eindhoven, Netherlands, NL-5656
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 63E
Dividend Analytics 63E
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 63E
Stock Valuation 63E
Financials 63E
Results | 2019 | Dynamics |